BayWas, Restructuring

BayWa's Restructuring Teeters as Auditor Exit Compounds Financial and Legal Woes

10.04.2026 - 17:55:27 | boerse-global.de

BayWa's rescue plan collapses as auditor PwC exits amid a €1B financing impasse, asset sale failures, and legal investigations into management disclosures.

BayWa's Restructuring Teeters as Auditor Exit Compounds Financial and Legal Woes - Foto: über boerse-global.de

The departure of auditor PricewaterhouseCoopers from German agricultural conglomerate BayWa is far from a routine change. It underscores a deepening crisis where financial shortfalls, legal investigations, and a standoff between owners and creditors are converging, leaving the company's future in doubt.

At the heart of the turmoil is a fresh financing gap of up to one billion euros. Negotiations over a new rescue package have reached an impasse, with the cooperative shareholders and a consortium of banks taking opposing stances. The owner side, led by Bayerische Raiffeisen-Beteiligungs-AG with about 37% and Austria's Raiffeisen Agrar Invest with over 30%, is resisting measures it equates to a destruction of asset value. The creditor banks, including DZ Bank, UniCredit, Commerzbank, Deutsche Bank, and LBBW, are demanding substantial concessions: partial debt haircuts, subordination agreements, and a long-term dividend waiver.

A critical pillar of the company's original recovery plan has collapsed. The intended partial sale of the renewable energy subsidiary BayWa r.e. has been derailed by a U.S. law—the so-called "One Big Beautiful Bill Act"—which severely worsened regulatory conditions for renewables. Initial management calculations projected proceeds of roughly 1.7 billion euros by 2028. That outlook has dimmed drastically; the EBITDA forecast for 2030 has been slashed to just 150 million euros. Of an overall restructuring target of four billion euros, only 1.3 billion is currently secured, forcing a fundamental overhaul of the rescue concept established just last May.

Operationally, BayWa is scrambling to generate liquidity through asset sales. The disposal of the Dutch subsidiary Cefetra is expected to yield a further tranche of 45 million euros by the end of April 2026. Combined with its deconsolidation, this should reduce bank debt by more than 600 million euros. Goldman Sachs holds the mandate for the sale of the New Zealand fruit subsidiary T&G Global, where proceeds of around 300 million euros are anticipated.

Should investors sell immediately? Or is it worth buying BayWa?

The company's governance and past disclosures are under intense scrutiny. PwC's exit as auditor was triggered by its issuance of an unqualified audit opinion for the 2023 financial year, despite BayWa having omitted significant financing risks in its management report. These undisclosed risks included conditions of a billion-euro loan and refinancing risks for a 500-million-euro bond. Germany's financial regulator BaFin officially reprimanded this failure, and the audit oversight body Apas has initiated professional disciplinary proceedings. PwC will remain to audit the 2025 accounts—a delicate transition, as those results are not expected until the fourth quarter of 2026 due to the pending revaluation of BayWa r.e.

Simultaneously, the Munich I public prosecutor's office is investigating former executives, including ex-CEO Marcus Pöllinger, on suspicion of breach of trust and misrepresenting the liquidity situation in the 2023 accounts. House searches were conducted in January. All accused are presumed innocent. Law firm TILP is also preparing damages lawsuits for shareholders who purchased stock between January 2022 and January 2026.

The restructuring's progress now hinges critically on the core creditor banks, led by DZ Bank and HVB. Without their agreement to extend a formal standstill agreement until autumn 2026, management lacks the legal foundation to proceed with the overhaul. The crisis is already impacting the banking system; Bavarian cooperative banks have written off 60% of a 220-million-euro loan note in their 2024 accounts.

BayWa at a turning point? This analysis reveals what investors need to know now.

Investors have borne the brunt, with the share price down approximately 34% over the past twelve months and trading about 20% below its 200-day moving average. The company has withdrawn its 2026 annual forecast and lowered its 2027 EBITDA target to around 140 million euros, with 1,300 jobs set to be cut by then. Two pivotal events will determine the next phase: a bank agreement and the audited 2025 financial statements. Neither is expected before the final quarter of 2026.

Ad

BayWa Stock: New Analysis - 10 April

Fresh BayWa information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated BayWa analysis...

So schätzen die Börsenprofis BayWas Aktien ein!

<b>So schätzen die Börsenprofis BayWas Aktien ein!</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
en | DE0005194005 | BAYWAS | boerse | 69119142 |